Moleculin Biotech, Inc.
Pharmaceutical company · Houston, Texas, United States · Nasdaq: MBRX
Moleculin Biotech, Inc. is a pharmaceutical company headquartered in Houston, Texas, United States. Its earliest recorded incorporation is in 2015. Its shares trade on Nasdaq under the ticker MBRX. It has reported private securities offerings to the US SEC, most recently $6 million sold in a notice filed in 2016.
Moleculin Biotech at a glance
What does Moleculin Biotech do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $6 million sold (2016).
Frequently asked questions about Moleculin Biotech
Where is Moleculin Biotech headquartered?
Moleculin Biotech, Inc. is headquartered in Houston, Texas, United States.
What does Moleculin Biotech do?
Moleculin Biotech, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Moleculin Biotech a public company?
Yes. Moleculin Biotech, Inc. trades on Nasdaq under the ticker MBRX.
When was Moleculin Biotech founded?
The earliest incorporation on record for Moleculin Biotech, Inc. is in 2015, according to public company registers.
Similar companies
- Marker Therapeutics, Inc.Houston, Texas, United States
- 7 Hills Pharma Inc.Houston, Texas, United States
- Decoy Therapeutics Inc.Houston, Texas, United States
- CNS Pharmaceuticals, Inc.Houston, Texas, United States
- Coya Therapeutics, Inc.Houston, Texas, United States
- Aravive, Inc.Houston, Texas, United States
- Beta Cat Pharmaceuticals, Inc.Houston, Texas, United States
- Bellicum Pharmaceuticals, IncHouston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences